Mutational analysis revealed that unlike C3, which exhibited high tumor mutation burden in FGFR3, KDM6A, and TBC1D12, C2 exhibited high tumor mutation burden in TP53 and FLG (Figures 2D–G). This evidence concerns the gene KDM6A and neoplasm.